In the realm of pharmaceutical development, peptides have emerged as a potent class of therapeutic agents. Theirs efficacy stems from their ability to precisely target cellular processes. However, guaranteeing the quality and safety of peptide therapeutics is paramount. This necessitates adherence to stringent manufacturing practices, with Good Man

Peptide companies in the United States have witnessed unprecedented growth, with the FDA approving a record number of peptide-based therapeutics in recent years. Indeed, these specialized molecules now account for over 5% of all approved drugs, underscoring their growing importance in modern medicine. The complex nature of peptide synthesis necessi